Three year financial snapshot

Key pro-forma financial information for the last three fiscal years for Symbion Health.

 A$ (millions)

 2003

2004 

 2005

 Pro-forma financial performance for year ending 30 June*      

Sales revenue

 

 

 

Pathology

427.4

526.5

569.1

 Diagnostic Imaging

 199.2

 276.2

 287.2

Consumer Products

 156.4

145.8

171.0

Pharmacy

 1,943.4

2,068.6

2,147.9

Unallocated

 5.2

2.1

0.6

Total Sales Revenue

2,731.6

3,019.3

3,175.8

EBITA

 

 

 

Pathology

52.1

68.1

82.0

Diagnostic Imaging

24.6

27.9

28.6

Consumer Products

 6.5

 15.7

 24.8

Pharmacy 

 42.3

 38.2

 32.6

Unallocated 

 (13.1)

 (10.6)

 (14.7)

 Total EBITA

 112.3

 139.3

 153.4

Amortisation

 (38.4)

 (37.7)

 (40.8)

EBIT

73.9

101.6

112.6

* The pro-forma financial information is prepared under Australian GAAP by combining the historical financial information of Symbion Pathology, Symbion Diagnostic Imaging, Symbion Pharmacy and Symbion Consumer. Pro-forma adjustments are made to the historical financial information to adjust for material discontinued activities, to exclude the impact of certain non-recurring items and to reflect the costs of operating as an independent company.